BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 36119504)

  • 1. Adjuvant chemotherapy may improve long-term outcomes in stage IB non-small cell lung cancer patients with previous malignancies: A propensity score-matched analysis.
    Zhou K; Zhao Y; Liang L; Cao J; Lin H; Peng Z; Mei J
    Front Oncol; 2022; 12():938195. PubMed ID: 36119504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Adjuvant Chemotherapy on Survival of Patients With 8th Edition Stage IB Non-Small Cell Lung Cancer.
    Xu Y; Wan B; Zhu S; Zhang T; Xie J; Liu H; Zhan P; Lv T; Song Y
    Front Oncol; 2021; 11():784289. PubMed ID: 35155190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propensity-matched analysis of adjuvant chemotherapy for completely resected Stage IB non-small-cell lung cancer patients.
    Li X; Zhang C; Sun Z; Yang F; Xiao R; Sui X; Jiang G; Zhong W; Wang J
    Lung Cancer; 2019 Jul; 133():75-82. PubMed ID: 31200832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative chemotherapy significantly improves survival of elderly patients with stage IB-II non-small cell lung cancer: A population-based study.
    Liu W; Ma S; Shi P; Zhang Y; Li M
    Cancer Med; 2023 May; 12(10):11254-11263. PubMed ID: 37031456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes for Surgery in Stage IA Large Cell Lung Neuroendocrine Compared With Other Types of Non-Small Cell Lung Cancer: A Propensity Score Matching Study Based on the Surveillance, Epidemiology, and End Results (SEER) Database.
    Zou L; Guo T; Ye L; Zhou Y; Chu L; Chu X; Ni J; Zhu Z; Yang X
    Front Oncol; 2020; 10():572462. PubMed ID: 33324549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overall Survival Analyses following Adjuvant Chemotherapy or Nonadjuvant Chemotherapy in Patients with Stage IB Non-Small-Cell Lung Cancer.
    Tu Z; Tian T; Chen Q; Li C
    J Oncol; 2021; 2021():8052752. PubMed ID: 34335761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non-small cell lung cancer.
    Zhang P; Duan J; Bai H; Wang Z; Gao S; Tan F; Gao Y; Wang X; Wan R; Xu J; He X; Feng X; Yu R; Sun J; Zhao Z; Fei K; Li N; He J; Wang J
    Thorac Cancer; 2021 Jan; 12(1):30-39. PubMed ID: 33111432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of adjuvant chemotherapy on survival for patients with completely resected high-risk stage IB NSCLC.
    Shen ZQ; Feng KP; Fang ZY; Xia T; Pan S; Ding C; Xu C; Ju S; Chen J; Li C; Zhao J
    J Cardiothorac Surg; 2024 Jan; 19(1):1. PubMed ID: 38166960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lobe-specific analysis of perioperative chemotherapy for non-small cell lung cancer patients.
    Lei X; Li T; Mao F; Ren F; Tang Q; Cao W; Zu L; Xu S
    Cancer Med; 2023 Aug; 12(16):16896-16905. PubMed ID: 37403701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant Chemotherapy for the Completely Resected Stage IB Nonsmall Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    He J; Shen J; Yang C; Jiang L; Liang W; Shi X; Xu X; He J
    Medicine (Baltimore); 2015 Jun; 94(22):e903. PubMed ID: 26039122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit of adjuvant chemotherapy for patients with stage IB non-small cell lung cancer: a systematic review and meta-analysis.
    Wang X; Chen D; Wen J; Mao Y; Zhu X; Fan M; Chen Y
    Ann Transl Med; 2021 Sep; 9(18):1430. PubMed ID: 34733982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative radiotherapy improves survival of patients with ypN2 non-small cell lung cancer after neoadjuvant chemotherapy followed by surgery - A propensity score matching study of the Surveillance, Epidemiology, and End Results database.
    Bao Y; Yang X; Men Y; Kang J; Sun X; Zhao M; Sun S; Yuan M; Ma Z; Hui Z
    Thorac Cancer; 2022 Feb; 13(3):404-411. PubMed ID: 34907665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of survival with adjuvant chemotherapy in patients with stage IB gastric cancer: a multicentre, observational, cohort study.
    Gao X; Li G; Deng J; Zhao L; Han W; Zhang N; Gao Y; Lu L; Wang S; Yu J; Yan J; Zhang G; Peng R; Zhang R; Fu Y; He F; Hu J; Wang W; Fan P; Si C; Gao P; Liang H; Chen H; Ji G; Shang L; Zhao Q; Zhang Z; Yang S; Wang Z; Xi H; Chen Y; Wu K; Nie Y
    Lancet Reg Health West Pac; 2024 Apr; 45():101031. PubMed ID: 38361774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of adjuvant chemotherapy on patients with stage IB non-small cell lung cancer with visceral pleural invasion.
    Kim BG; Choi J; Lee SK; Choi SI; Park CK; Sim JK; Lee H; Kim SH; Sohn JW; Yoon HJ; Lee SY; Park DW
    J Thorac Dis; 2024 Feb; 16(2):875-883. PubMed ID: 38505035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion.
    Xie J; Zhang X; Hu S; Peng WD; Xu B; Li Y; Zhang SJ; Li Q; Li C
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2231-2239. PubMed ID: 32533405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Nomogram to Predict the Overall Survival of Patients With Resected T1-2N0-1M0 Non-Small Cell Lung Cancer and to Identify the Optimal Candidates for Adjuvant Chemotherapy in Stage IB or IIA Non-Small Cell Lung Cancer Patients.
    Wang W; Zhou J
    Cancer Control; 2023; 30():10732748231197973. PubMed ID: 37703536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy and survival outcomes in older women with HR+/HER2- breast cancer: a propensity score-matched retrospective cohort study using the SEER database.
    Ma X; Wu S; Zhang X; Chen N; Yang C; Yang C; Cao M; Du K; Liu Y
    BMJ Open; 2024 Mar; 14(3):e078782. PubMed ID: 38490656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of neoadjuvant radiotherapy, adjuvant radiotherapy, and chemotherapy-only on survival of locally advanced non-small cell lung Cancer undergoing surgery: a propensity-matched analysis.
    Wang X; Yin C; Su S; Li X; Wang C; Zhang C; Liu M
    BMC Cancer; 2018 Nov; 18(1):1067. PubMed ID: 30400782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Population-Based Study on the Prognostic factors and Efficacy of Adjuvant Chemotherapy in the Postoperative Stage for Patients with Stage IIA Non-Small Cell Lung Cancer.
    Wang W; Teng F; Bu S; Xu W; Cai QC; Jiang YQ; Wang ZQ
    Risk Manag Healthc Policy; 2022; 15():1581-1592. PubMed ID: 36046766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
    Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.